Arecor Therapeutics plc

77.50pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:ARECHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 5Y CAGR (18.86%)
Div yield —
ROE (1.44%)
Biotechnology
Beta (5Y) 0.09
PE TTM 154.0
TSR TTM 8.39%
Mkt cap £35.11M
ROIC (872.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
90p
16.12%
(22.57%)
Hold 0|9|1|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share£
1.61
1.67
1.60
1.75
17.74%
15.49%
(0.17%)
5.83%
Revenue£M
2.218
2.212
2.220
2.195
2.01%
0.99%
(4.02%)
(2.67%)
Peers (US$47.70M)
Cap (US$)
PE
39.28M
—
47.50M
—
Capital
TTM
5Y
10Y
Leveragex
0.454
0.343
0.309
EBIT/Intx
0.943
0.254
0.257
Own earn%
69.82
(180.85)
(169.98)
Sh yield%
8.31
35.87
34.30
Owners
Insiders/Inst%
11.00
77.56
Short interest%
5.00
SBC / revenue%
5.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
25–34
$1 testx
—
Incr. ROIC%
2